Pangenomic Health Inc.
PGHIF
$1.46
$0.3632.74%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.98% | 10.77% | 4.73% | 51.75% | -82.30% |
| Total Depreciation and Amortization | -90.00% | -93.55% | -95.24% | -80.43% | -56.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.12% | -51.50% | -65.70% | -89.72% | 986.71% |
| Change in Net Operating Assets | -94.00% | -75.06% | 19.45% | 71.78% | 14.11% |
| Cash from Operations | -1,726.47% | -3,159.57% | -353.72% | 57.78% | 86.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 392.88% | 377.23% | -39.79% | -54.67% | -88.79% |
| Total Debt Repaid | -- | -- | -269.07% | -156.36% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2,405.88% | -5,975.00% | -- |
| Cash from Financing | 2,282.36% | 3,952.48% | 347.38% | -60.30% | -89.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 254.10% | 466.67% | 208.80% | -148.57% | -310.34% |